157 related articles for article (PubMed ID: 25476856)
21. HOXC11 positively regulates the long non-coding RNA HOTAIR and is associated with poor prognosis in colon adenocarcinoma.
Gong N; Li F; Wang Y; Li Z; Wang W; Gong T; Meng X; Chen H
Exp Ther Med; 2021 Nov; 22(5):1310. PubMed ID: 34630664
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract][Full Text] [Related]
23. HOXC11 drives lung adenocarcinoma progression through transcriptional regulation of SPHK1.
Peng X; Liu X; Hu W; Zhou Y; Ouyang L; Peng X; Long Y; Sun J; Tao T; Chen L; Shi Y; Tao Y; Xiao D; Liu S
Cell Death Dis; 2023 Feb; 14(2):153. PubMed ID: 36823149
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
[TBL] [Abstract][Full Text] [Related]
25. miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2.
Ma Y; Zhang H; He X; Song H; Qiang Y; Li Y; Gao J; Wang Z
Tumour Biol; 2015 Nov; 36(11):8389-98. PubMed ID: 26018509
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance and therapeutic potential of prostate cancer antigen-1/ALKBH3 in human renal cell carcinoma.
Hotta K; Sho M; Fujimoto K; Shimada K; Yamato I; Anai S; Harada H; Tsujikawa K; Konishi N; Shinohara N; Nakajima Y
Oncol Rep; 2015 Aug; 34(2):648-54. PubMed ID: 26035443
[TBL] [Abstract][Full Text] [Related]
27. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.
Ishida M; Mikami S; Shinojima T; Kosaka T; Mizuno R; Kikuchi E; Miyajima A; Okada Y; Oya M
Int J Cancer; 2015 Jul; 137(2):299-310. PubMed ID: 25523818
[TBL] [Abstract][Full Text] [Related]
28. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
[TBL] [Abstract][Full Text] [Related]
30. The expression of RNA-binding protein RBM38 decreased in renal cell carcinoma and represses renal cancer cell proliferation, migration, and invasion.
Huang W; Wei XL; Ni W; Cao M; Meng L; Yang H
Tumour Biol; 2017 May; 39(5):1010428317701635. PubMed ID: 28459215
[TBL] [Abstract][Full Text] [Related]
31. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
[TBL] [Abstract][Full Text] [Related]
32. MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition.
Machackova T; Mlcochova H; Stanik M; Dolezel J; Fedorko M; Pacik D; Poprach A; Svoboda M; Slaby O
Tumour Biol; 2016 Nov; 37(11):14653-14658. PubMed ID: 27619681
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic expression of pontin in renal cell carcinoma correlates with tumor invasion, metastasis and patients' survival.
Zhang X; Ren J; Yan L; Tang Y; Zhang W; Li D; Zang Y; Kong F; Xu Z
PLoS One; 2015; 10(3):e0118659. PubMed ID: 25751257
[TBL] [Abstract][Full Text] [Related]
34. Targeted p21(WAF1/CIP1) activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma.
Wang C; Tang K; Li Z; Chen Z; Xu H; Ye Z
Urol Oncol; 2016 Feb; 34(2):59.e23-34. PubMed ID: 26421587
[TBL] [Abstract][Full Text] [Related]
35. [Correlation between the PTEN/MMAC1/TEP1 expression and cell proliferation and apoptosis in human renal cell carcinoma (RCC)].
Li JY; Cao RF; Wang H; Xie QX; Wang GX; Xiong LS; Miao YR
Ai Zheng; 2003 Jun; 22(6):607-11. PubMed ID: 12948410
[TBL] [Abstract][Full Text] [Related]
36. miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.
Peng H; Wang X; Zhang P; Sun T; Ren X; Xia Z
Int J Clin Exp Pathol; 2015; 8(2):2259-66. PubMed ID: 25973137
[TBL] [Abstract][Full Text] [Related]
37. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).
Evelönn EA; Degerman S; Köhn L; Landfors M; Ljungberg B; Roos G
Tumour Biol; 2016 Aug; 37(8):10219-28. PubMed ID: 26831665
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
40. Impact of an altered PROX1 expression on clinicopathology, prognosis and progression in renal cell carcinoma.
Lv T; Liu Y; Zhang J; Xu L; Zhu Y; Yin H; An H; Lin Z; Xie Y; Chen L
PLoS One; 2014; 9(5):e95996. PubMed ID: 24797520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]